Template-constrained macrocyclic peptides prepared from natièe, unprotected precursors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 40, 2013, Pages

  Lawson, Kenneth È ^a   Rose, Tristan E ^a   Harran, Patrick G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; MACROCYCLIC COMPOUND;

ARTICLE; CYCLIZATION; IN VITRO STUDY; PRECURSOR; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; ROOM TEMPERATURE;

CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MACROCYCLIC COMPOUNDS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PALLADIUM; PEPTIDES, CYCLIC; PROTEIN CONFORMATION;

EID: 84885032816     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311706110     Document Type: Article

References (91)

1. Chène P (2006) Drugs targeting protein-protein interactions. ChemMedChem 1(4): 400-411.
2. Berg T (2008) Small-molecule inhibitors of protein-protein interactions. Curr Opin Drug Discov Devel 11(5):666-674.
3. Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream. Nat Rev Drug Discov 3(4):301-317.
4. Souroujon MC, Mochly-Rosen D (1998) Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol 16(10):919-924.
5. DeLano WL, Ultsch MH, de Vos AM, Wells JA (2000) Convergent solutions to binding at a protein-protein interface. Science 287(5456):1279-1283.
6. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X (L). Cell 87(4):619-628.
7. Mackintosh C (2004) Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J 381(Pt 2):329-342.
8. Cochran AG (2000) Antagonists of protein-protein interactions. Chem Biol 7(4):R85-R94.
9. Lu L, Arakaki AK, Lu H, Skolnick J (2003) Multimeric threading-based prediction of protein-protein interactions on a genomic scale: Application to the Saccharomyces cerevisiae proteome. Genome Res 13(6A):1146-1154.
10. Davey NE, Edwards RJ, Shields DC (2007) The SLiMDisc server: Short, linear motif discovery in proteins. Nucleic Acids Res 35(Web Server issue):W455-9.
11. Edwards RJ, Davey NE, Shields DC (2007) SLiMFinder: A probabilistic method for identifying over-represented, convergently evolved, short linear motifs in proteins. PLoS ONE 2(10):e967.
12. Neduva V, Russell RB (2006) Peptides mediating interaction networks: New leads at last. Curr Opin Biotechnol 17(5):465-471.
13. Davey NE, et al. (2012) Attributes of short linear motifs. Mol Biosyst 8(1):268-281.
14. Ahrens VM, Bellmann-Sickert K, Beck-Sickinger AG (2012) Peptides and peptide conjugates: Therapeutics on the upward path. Future Med Chem 4(12):1567-1586.
15. Pillutla RC, et al. (2002) Peptides identify the critical hotspots involved in the biological activation of the insulin receptor. J Biol Chem 277(25):22590-22594.
16. Bogan AA, Thorn KS (1998) Anatomy of hot spots in protein interfaces. J Mol Biol 280(1):1-9.
17. Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450(7172):1001-1009.
18. Moreira IS, Fernandes PA, Ramos MJ (2007) Hot spots-a review of the proteinprotein interface determinant amino-acid residues. Proteins 68(4):803-812.
19. Wilson AJ (2009) Inhibition of protein-protein interactions using designed molecules. Chem Soc Rev 38(12):3289-3300.
20. Groner B, ed (2009) Peptides as Drugs: Discovery and Development, Wiley-VCH, Weinheim, Germany, pp xv, 226.
21. Sehgal A (2002) Recent developments in peptide-based cancer therapeutics. Curr Opin Drug Discov Devel 5(2):245-250.
22. Vally M, Seenu S, Pillarisetti S (2006) Emerging peptide therapeutics for inflammatory diseases. Curr Pharm Biotechnol 7(4):241-246.
23. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: Science and market. Drug Discov Today 15(1-2):40-56.
24. White CJ, Yudin AK (2011) Contemporary strategies for peptide macrocyclization. Nat Chem 3(7):509-524.
25. Deber CM, Madison V, Blout ER (1976) Why cyclic peptides: Complementary approaches to conformations. Acc Chem Res 9(3):106-113.
26. Marsault E, Peterson ML (2011) Macrocycles are great cycles: Applications, opportunities, and challenges of synthetic macrocycles in drug discovery. J Med Chem 54(7):1961-2004.
27. Driggers EM, Hale SP, Lee J, Terrett NK (2008) The exploration of macrocycles for drug discovery-an underexploited structural class. Nat Rev Drug Discov 7(7):608-624.
28. Kawakami T, et al. (2009) Diverse backbone-cyclized peptides via codon reprogramming. Nat Chem Biol 5(12):888-890.
29. Gartner ZJ, et al. (2004) DNA-templated organic synthesis and selection of a library of macrocycles. Science 305(5690):1601-1605.
30. Heinis C, Rutherford T, Freund S, Winter G (2009) Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nat Chem Biol 5(7):502-507.
31. Smith JM, Vitali F, Archer SA, Fasan R (2011) Modular assembly of macrocyclic organopeptide hybrids using synthetic and genetically encoded precursors. Angew Chem Int Ed Engl 50(22):5075-5080.
32. Ng S, Jafari MR, Derda R (2012) Bacteriophages and viruses as a support for organic synthesis and combinatorial chemistry. ACS Chem Biol 7(1):123-138.
33. Bird GH, et al. (2010) Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic. Proc Natl Acad Sci USA 107(32):14093-14098.
34. Davies JS (2003) The cyclization of peptides and depsipeptides. J Pept Sci 9(8):471-501.
35. Thakkar A, Trinh TB, Pei D (2013) Global analysis of peptide cyclization efficiency. ACS Comb Sci 15(2):120-129.
36. Montalbetti CAGN, Falque V (2005) Amide bond formation and peptide coupling. Tetrahedron 61(46):10827-10852.
37. Jackson DY, King DS, Chmielewski J, Singh S, Schultz PG (1991) General approach to the synthesis of short α-helical peptides. J Am Chem Soc 113(24):9391-9392.
38. Giebel LB, et al. (1995) Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry 34(47):15430-15435.
39. Blackwell HE, Grubbs RH (1998) Highly efficient synthesis of covalently cross-linked peptide helices by ring-closing metathesis. Angew Chem Int Ed 37(23):3281-3284.
40. Jacobsen O, et al. (2011) Stapling of a 3(10)-helix with click chemistry. J Org Chem 76(5):1228-1238.
41. Pehere AD, Abell AD (2012) New β-strand templates constrained by Huisgen cycloaddition. Org Lett 14(5):1330-1333.
42. Chouhan G, James K (2011) CuAAC macrocyclization: High intramolecular selectivity through the use of copper-tris(triazole) ligand complexes. Org Lett 13(10):2754-2757.
43. Kates SA, et al. (1993) A novel, convenient, 3-dimensional orthogonal strategy for solid-phase synthesis of cyclic-peptides. Tetrahedron Lett 34(10):1549-1552.
44. Lundquist JT, 4th, Pelletier JC (2002) A new tri-orthogonal strategy for peptide cyclization. Org Lett 4(19):3219-3221.
45. Schmidt U, Langner J (1997) Cyclotetrapeptides and cyclopentapeptides: Occurrence and synthesis. J Pept Res 49(1):67-73.
46. Jackson S, et al. (1994) Template-constrained cyclic peptides: Design of high-affinity ligands for GPIIb/IIIa. J Am Chem Soc 116(8):3220-3230.
47. Boger DL, Myers JB (1991) Design and synthesis of a conformational analog of deoxybouvardin. J Org Chem 56(18):5385-5390.
48. Marsault E, et al. (2008) Efficient parallel synthesis of macrocyclic peptidomimetics. Bioorg Med Chem Lett 18(16):4731-4735.
49. Ernest I, Kalvoda J, Rihs G, MutterM(1990) Three novel mimics for the construction of sterically constrained protein turn models. Tetrahedron Lett 31(28):4011-4014.
50. Cheng RP, Suich DJ, Cheng H, Roder H, DeGrado WF (2001) Template-constrained somatostatin analogues: A biphenyl linker induces a type-V' turn. J Am Chem Soc 123(50):12710-12711.
51. Zhao HD, et al. (2008) Acid promoted cinnamyl ion mobility within peptide derived macrocycles. J Am Chem Soc 130(42):13864-13866.
52. Wei Q, Harran S, Harran PG (2003) Methods to initiate synthetic re-structuring of peptides. Tetrahedron 59(45):8947-8954.
53. Lawson KV, Rose TE, Harran PG (2011) Synthesis of a designed sesquiterpenoid that forms useful composites with peptides and related oligomers. Tetrahedron Lett 52(6): 653-654.
54. Lawson KV, Rose TE, Harran PG (2013) Template-induced macrocycle diversity through large ring-forming alkylations of tryptophan. Tetrahedron 69(36):7683-7691.
55. Trost BM, Zhang T, Sieber JD (2010) Catalytic asymmetric allylic alkylation employing heteroatom nucleophiles: A powerful method for C-X bond formation. Chem Sci 1(4): 427-440.
56. Trost BM (2004) Asymmetric allylic alkylation, an enabling methodology. J Org Chem 69(18):5813-5837.
57. Fürstner A, Weintritt H (1998) Total synthesis of roseophilin. J Am Chem Soc 120(12): 2817-2825.
58. Fürstner A, Krause H (1999) Flexible synthesis of metacycloprodigiosin and functional derivatives thereof. J Org Chem 64(22):8281-8286.
59. Trost BM, Ohmori M, Boyd SA, Okawara H, Brickner SJ (1989) Palladium-catalyzed synthesis of macrocycles. A total synthesis of (-)-aspochalasin B. J Am Chem Soc 111(21):8281-8284.
60. Trost BM, Verhoeven TR (1980) Cyclization catalyzed by palladium(0). Initial studies and macrolide formation. J Am Chem Soc 102(14):4743-4763.
61. Evans LA, et al. (2008) Counterintuitive kinetics in Tsuji-Trost allylation: Ion-pair partitioning and implications for asymmetric catalysis. J Am Chem Soc 130(44): 14471-14473.
62. Trost BM, Bunt RC (1993) On the nature of the ion pair as a nucleophile in Pd catalyzed alkylations with dienyl carboxylates. Tetrahedron Lett 34(47):7513-7516.
63. Rotstein BH, Rai V, Hili R, Yudin AK (2010) Synthesis of peptide macrocycles using unprotected amino aldehydes. Nat Protoc 5(11):1813-1822.
64. Hili R, Rai V, Yudin AK (2010) Macrocyclization of linear peptides enabled by amphoteric molecules. J Am Chem Soc 132(9):2889-2891.
65. Londregan AT, Farley KA, Limberakis C, Mullins PB, Piotrowski DW (2012) A new and useful method for the macrocyclization of linear peptides. Org Lett 14(11):2890-2893.
66. Jagasia R, Holub JM, Bollinger M, Kirshenbaum K, Finn MG (2009) Peptide cyclization and cyclodimerization by Cu(I)-mediated azide-alkyne cycloaddition. J Org Chem 74(8):2964-2974.
67. Punna S, Kuzelka J, Wang Q, Finn MG (2005) Head-to-tail peptide cyclodimerization by copper-catalyzed azide-alkyne cycloaddition. Angew Chem Int Ed Engl 44(15): 2215-2220.
68. Collins JC, James K (2012) Emac: A comparative index for the assessment of macrocyclization efficiency. Med Chem Comm 3(12):1489-1495.
69. Pneumatikakis G, Chassapis C, Rontoyianni A (1993) Complexes of palladium(II) chloride with histidine methylester, X-ray crystal structure of Pd(HisOMe)Cl2. Ternary complexes of palladium(II) with histidine methylester and nucleosides. J Inorg Biochem 49(2):83-96.
70. L. Best S, et al. (1997) Gold(III) and palladium(II) complexes of glycylglycyl-L-histidine: Crystal structures of [AuIII(Gly-Gly-L-His-H-2)]Cl H2O and [PdII(Gly-Gly-L-His-H-2)] 1.5H2O and HiseNH deprotonation. J Chem Soc Dalt Trans (15):2587-2596.
71. Pitner TP, Wilson EW, Martin RB (1972) Properties of palladium(II) complexes of peptides and histidine in basic solutions. Inorg Chem 11(4):738-742.
72. Klingensmith LM, Strieter ER, Barder TE, Buchwald SL (2006) New insights into Xantphos/Pd-catalyzed C-N bond forming reactions: A structural and kinetic study. Organometallics 25(1):82-91.
73. Collins JC, et al. (2012) Macrocyclizations for medicinal chemistry: Synthesis of druglike macrocycles by high-concentration Ullmann coupling. J Org Chem 77(24):11079-11090.
74. Dijkstra G, Kruizinga WH, Kellogg RM (1987) An assessment of the causes of the "cesium effect". J Org Chem 52(19):4230-4234.
75. Trost BM, Cossy J (1982) Palladium-mediated macroheterocyclization. A synthesis of inandenin-12-one. J Am Chem Soc 104(24):6881-6882.
76. Mattern IE, Pittard J (1971) Regulation of tyrosine biosynthesis in Escherichia coli K-12: Isolation and characterization of operator mutants. J Bacteriol 107(1):8-15.
77. Geurink PP, et al. (2013) Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites. J Med Chem 56(3):1262-1275.
78. Malesevic M, Strijowski U, Bächle D, Sewald N (2004) An improved method for the solution cyclization of peptides under pseudo-high dilution conditions. J Biotechnol 112(1-2):73-77.
79. Scott LT, Rebek J, Ovsyanko L, Sims CL (1977) Organic chemistry on the solid phase. Site-site interactions on functionalized polystyrene. J Am Chem Soc 99(2):625-626.
80. Botti P, Pallin TD, Tam JP (1996) Cyclic peptides from linear unprotected peptide precursors through thiazolidine formation. J Am Chem Soc 118(42):10018-10024.
81. Wöhr T, et al. (1996) Pseudo-prolines as a solubilizing, structure-disrupting protection technique in peptide synthesis. J Am Chem Soc 118(39):9218-9227.
82. Kim Y-W, Grossmann TN, Verdine GL (2011) Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin metathesis. Nat Protoc 6(6):761-771.
83. Kessler H (1982) Conformation and biological activity of cyclic peptides. Angew Chem Int Ed Engl 21(7):512-523.
84. Wüthrich K (1976) NMR in Biological Research: Peptides and Proteins (American Elsevier, Amsterdam).
85. Saitô H (1986) Conformation-dependent 13C chemical shifts: A new means of conformational characterization as obtained by high-resolution solid-state 13C NMR. Magn Reson Chem 24(10):835-852.
86. Wishart DS, Sykes BD, Richards FM (1991) Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol 222(2):311-333.
87. Cierpicki T, Otlewski J (2001) Amide proton temperature coefficients as hydrogen bond indicators in proteins. J Biomol NMR 21(3):249-261.
88. Baxter NJ, Williamson MP (1997) Temperature dependence of 1H chemical shifts in proteins. J Biomol NMR 9(4):359-369.
89. Bara YA, Friedrich A, Kessler H, Molter M (1978) Peptidkonformationen, II: 1H-NMRUntersuchungen zur Konformation von cyclo(-Phe3Gly2-). Chem Ber 111(3):1045-1057.
90. Rozek A, Powers J-PS, Friedrich CL, Hancock REW (2003) Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 42(48): 14130-14138.
91. Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: Incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16(28):3185-3203.